FULMINANT HEPATITIS IN FATAL DENGUE SHOCK SYNDROME PATIENTS

 

Nguyen Trong Lan, Nguyen Thanh Hung, Nguyen Bach Hue, Nguyen Thi Khen,
Do Quang Ha, Vu Thi Que Huong, Vicent Deubel, Michel Huerre

 

Six fatal Dengue shock syndrome patients with fulminant hepatitis and encephalopathy were observed during a 11-month period from October 1996 to September 1997 at Children’s Hospital N01, HoChiMinh city, Vietnam.

Five patients had marked elevation of liver transaminases (aspartate and alanine aminotransferases); transaminase level measuring in one case was not done, Histopathologic examination of post-morterm liver specimens revealed findings of acute hepatitis such as hepatic necrosis, steatosis, appearance of Councilman bodies. Reverse Transcription Polymerase Chain Reaction (RT-PCR) with blood samples and / or in situ Polymerase Chain Reaction with liver specimens detected RNAS of serotype DEN-3 in all 6 cases.

The result showed that liver involvement plays an important role in the outcome of Dengue shock patients, and fulminant hepatitis in Dengue hemorrhagic fever has been a real entity in Vietnam as well as other countries worldwide.

Summary

Dengue viruses were prevalent in Southern Vietnam in 1998 and 438.98 DHF cases/100,000 population with 342 deaths were recorded. The number of DHF patients and deaths per 100,000 population have respectively increased 152.41% and 151.80% compared with those of 1997 DHF outbreak. The 1998 DHF epidemic was the largest one since 1963 up to now. A total of 219 Dengue viruses were isolated from DHF patient sera, in which there were 26 DEN-1, 27 DEN-2, 162 DEN-3 and 4 DEN-4. 65.88% of isolates were recovered from children under 14 years old. Comparing to 1997 DHF epidemic, the Dengue serotype variations in 1998 were as follows: DEN-1 decreased from 14.06% to 11.87%. DEN-2 decreased from 42.18% to 12.32%, DEN-3 increased from 42.18% to 73.97% and there was re-emergence of DEN-4 after 5 years of its absence. The re-emergence of DEN-3 since 1994 has provoked the largest DHF epidemics in 1998. This emerging trend will likely continue, therefore it is a reminder that active surveillance and effective prevention program must be implemented without delay in the first trimester of the year.